The Nucleolus and Ribosome Assembly
Every second, a growing mammalian cell must build roughly 10 million new ribosomes. This effort simply keeps pace with its own division. Each ribosome contains four different RNA molecules and around 80 different proteins. All of these must find each other, fold correctly, and assemble in the right order. The ribosome is never complete or functional until the last step is done. This staggering logistical problem is solved inside a single, membraneless region of the nucleus called the nucleolus. It is the busiest factory in the cell. Paradoxically, it is an organelle with no membrane at all. The nucleolus matters because ribosome production sets the ceiling on how fast a cell can make protein. Protein synthesis capacity in turn limits growth, division, and repair. Cells devote a huge fraction of their transcriptional and metabolic budget to this task. In an actively growing cell, upward of 60% of all transcription can be traced to ribosome biogenesis. Most of the cell's ATP consumption during growth phases can be traced there too. Because the demand is so central, the nucleolus is also a sensitive barometer of cell stress, nutrient status, and cancer risk. Nucleolar size and activity are classic diagnostic features. Pathologists have used them for over a century to grade tumors. This practice began long before anyone knew what a nucleolus actually did. The big picture is this: the nucleolus is not a static structure built once and left alone. It is a self-organizing biochemical assembly line. It forms anew around actively transcribed ribosomal RNA genes each time a cell exits mitosis. It dissolves again when transcription stops. Its existence depends entirely on ongoing chemical activity. Stop transcribing ribosomal RNA, and the nucleolus disappears within minutes. This makes it one of the best-studied examples of a "membraneless organelle." Such a compartment is built by biochemistry and phase behavior rather than by a lipid bilayer. This article explains how the nucleolus concentrates the machinery for ribosomal RNA synthesis and processing. It also explains how pre-ribosomal particles are built in an ordered, quality-controlled sequence. Finally, it covers classic experiments that revealed the nucleolus's structure and dynamic, liquid-like nature. These range from silver-stained chromosome loops to modern fluorescence recovery after photobleaching.
- The nucleolus assembles around clusters of ribosomal RNA (rRNA) genes called nucleolar organizer regions (NORs), which are transcribed by RNA polymerase I.
- It has three nested subcompartments — fibrillar center, dense fibrillar component, and granular component — corresponding to sequential stages of rRNA synthesis, processing, and subunit assembly.
- The nucleolus has no membrane; it forms by liquid-liquid phase separation of RNA and protein, dissolving and reforming with the cell cycle.
- Ribosomal proteins are made in the cytoplasm and imported through nuclear pores to join rRNA in the nucleolus; assembled subunits exit through the same pores.
- Barbara McClintock's cytogenetics and Oscar Miller's electron micrographs of "Christmas tree" transcription units provided direct visual proof of nucleolar rRNA synthesis.
- Nucleolar stress signaling links ribosome biogenesis defects to p53 stabilization, connecting this organelle directly to cancer biology and diseases called ribosomopathies.
The nucleolus is a self-assembling, membraneless factory, built around actively transcribed ribosomal RNA genes, that manufactures and quality-checks ribosomal subunits from raw rRNA and imported proteins.
The core idea
The nucleolus is the site within the nucleus where ribosomal RNA is synthesized, processed, and assembled with ribosomal proteins into the large and small ribosomal subunits. It is not bounded by a membrane, which distinguishes it fundamentally from organelles like the mitochondrion or the ER. Instead, it exists because a huge local concentration of RNA polymerase I, ribosomal DNA (rDNA), nascent rRNA transcripts, and hundreds of processing and assembly factors creates a distinct biochemical and biophysical environment — a droplet-like phase separated from the surrounding nucleoplasm, held together by multivalent interactions between RNA and RNA-binding proteins with intrinsically disordered regions. Each human cell contains roughly 200 to 400 copies of the ribosomal RNA gene, organized in tandem repeats on the short arms of five acrocentric chromosome pairs (chromosomes 13, 14, 15, 21, and 22 in humans). These chromosomal loci are the nucleolar organizer regions, or NORs. When a cell exits mitosis, RNA polymerase I begins transcribing rDNA at active NORs, and the nucleolus reforms de novo around this transcriptional activity. Because nucleolar existence is contingent on transcription, the nucleolus is best understood not as a "thing" but as a process made visible — a structure that exists only because rRNA synthesis is happening continuously. The product of this factory is not one molecule but an entire macromolecular machine: the ribosome. A eukaryotic ribosome comprises a small subunit (40S in mammals) and a large subunit (60S), which together form the 80S ribosome. The small subunit contains the 18S rRNA plus about 33 ribosomal proteins; the large subunit contains 28S, 5.8S, and 5S rRNAs plus roughly 47 ribosomal proteins. Three of these four rRNAs (18S, 5.8S, and 28S) are transcribed together as a single long precursor inside the nucleolus and then cleaved apart; the fourth, 5S rRNA, is transcribed separately by RNA polymerase III, largely outside the nucleolus proper, and imported into the assembly line. This article builds toward Ribosomes: Structure and Function, where the finished machine and its catalytic mechanism are treated in full.
Mechanism
Step 1 — Transcription of the 45S pre-rRNA. RNA polymerase I binds rDNA promoters within active NORs, assisted by the transcription factors UBF (upstream binding factor) and SL1 (selectivity factor 1), and transcribes a single long precursor transcript. In humans this is called the 47S (or 45S, depending on convention) pre-rRNA, containing the 18S, 5.8S, and 28S rRNA sequences separated by internal and external transcribed spacers that will be discarded. A single nucleolus can contain hundreds of rDNA genes being transcribed simultaneously, each studded with dozens of RNA polymerase I molecules, producing a visually striking "Christmas tree" pattern of increasingly long nascent transcripts along each gene, first captured directly by electron microscopy (see Evidence below).
Step 2 — Co-transcriptional processing begins in the fibrillar center and dense fibrillar component. Even before transcription of a single rRNA gene finishes, small nucleolar ribonucleoprotein particles (snoRNPs) bind the nascent transcript. Box C/D snoRNPs guide 2′-O-methylation of specific ribose sugars; box H/ACA snoRNPs guide pseudouridylation of specific uridines. These chemical modifications, numbering well over 100 sites across the mature rRNAs, fine-tune rRNA folding and ribosome function. The very first snoRNP to assemble, U3 snoRNP, is essential for the first cleavages that separate the transcript into pre-40S and pre-60S processing streams.
Step 3 — Cleavage of pre-rRNA into subunit-specific precursors. A cascade of endonucleolytic and exonucleolytic cuts, carried out by dedicated nucleases, removes the external and internal transcribed spacers and separates the 18S rRNA (destined for the small subunit) from the 5.8S and 28S rRNAs (destined for the large subunit). This occurs in an ordered, hierarchical sequence — cut one spacer, and only then can the next enzyme access its site — which acts as a built-in checkpoint: if an earlier step fails, later cuts cannot proceed, and defective intermediates are degraded rather than passed forward.
Step 4 — Assembly with ribosomal proteins and import of 5S rRNA. As processing proceeds, ribosomal proteins — synthesized on cytoplasmic ribosomes and imported through the nuclear pore complex with the help of dedicated karyopherins — bind their rRNA partners in a defined temporal order, not randomly. The 5S rRNA, transcribed separately by RNA polymerase III in the nucleoplasm, is loaded together with ribosomal proteins RPL5 and RPL11 as a pre-formed 5S RNP that docks onto the maturing pre-60S particle. Roughly 200 distinct assembly factors — ATPases, GTPases, kinases, and RNA helicases — transiently bind and release in sequence, acting like a scaffold and quality-control crew rather than becoming part of the final ribosome.
Step 5 — Maturation in the granular component and nucleoplasmic quality control. Pre-40S and pre-60S particles migrate outward from the dense fibrillar component into the granular component, the outermost and largest nucleolar subregion, where the bulk of protein assembly and particle compaction occurs. Immature particles carry placeholder proteins and assembly factors that must be stripped off and exchanged for final ribosomal proteins before export is permitted — a proofreading mechanism ensuring that incompletely folded or incorrectly assembled subunits are retained and either fixed or degraded rather than released into the cytoplasm.
Step 6 — Nuclear export. Mature-enough pre-40S and pre-60S particles are handed to export receptors (notably exportin-1/CRM1 acting through adaptor proteins) and pass through nuclear pore complexes into the cytoplasm. Final maturation steps — including the very last proofreading cleavages and the loading of a handful of remaining proteins — occur in the cytoplasm, so that a subunit only becomes translation-competent after passing several checkpoints on both sides of the nuclear envelope. The two subunits do not join into a functional 80S ribosome until they encounter an mRNA and initiation factors during translation initiation, which is covered in Ribosomes: Structure and Function.
Why no membrane is needed. The nucleolus's three subregions are not membrane-bound compartments but concentration gradients of biochemical activity, maintained by liquid-liquid phase separation. Nucleolar proteins such as nucleophosmin (NPM1) and fibrillarin contain intrinsically disordered, low-complexity domains that make many weak, multivalent contacts with rRNA and with each other. These contacts drive spontaneous demixing from the surrounding nucleoplasm, similar to oil droplets separating from water, but tuned so that different proteins partition into different sub-droplets (fibrillar center vs. dense fibrillar component vs. granular component) based on their particular stickiness and the maturation stage of RNA they bind. This explains why nucleoli behave like liquid droplets that can fuse, drip, and reform, and why they vanish within minutes if RNA polymerase I transcription is inhibited (for example by the drug actinomycin D at low doses) — remove the RNA scaffold, and the phase separation collapses.
The evidence
Barbara McClintock and the discovery of the nucleolar organizer (1934). Working with maize chromosomes, McClintock identified a specific constricted region on certain chromosomes that was always physically associated with the nucleolus and was required for its formation. She named this locus the "nucleolar organizer" and showed cytologically that chromosome breaks separating this region from the rest of the chromosome produced fragments that failed to organize a nucleolus, while the fragment retaining the organizer region did. This was the first direct evidence linking a specific chromosomal locus to nucleolar formation, decades before anyone knew the region contained rRNA genes.
Ritossa and Spiegelman: molecular identification of rDNA (1965). Ferruccio Ritossa and Sol Spiegelman used DNA-RNA hybridization in Drosophila to show that ribosomal RNA specifically hybridizes to DNA located at the nucleolar organizer region on the X and Y chromosomes. Crucially, they compared flies with one, two, or three doses of the nucleolar organizer (using a partial deletion, "bobbed," mutant background) and found that rRNA gene dosage — the number of rDNA repeats — scaled with the number of NOR copies, directly proving that the NOR is the physical location of the ribosomal RNA genes themselves, not merely a region that happens to sit near the nucleolus.
Oscar Miller's electron micrographs: watching transcription directly (late 1960s). Oscar L. Miller Jr. developed a spreading technique that gently lysed nuclei and spread their chromatin content onto grids for electron microscopy without shearing away nascent transcripts. Applied to amphibian oocyte nucleoli — chosen because oocytes contain hugely amplified rDNA, up to a million extra copies, to stockpile ribosomes for early embryogenesis — this technique produced now-iconic images. Each rDNA gene appeared as an axis studded with a graded series of increasingly long fibers, each fiber being a nascent RNA transcript attached to an RNA polymerase molecule, giving the classic "Christmas tree" or "feather" appearance. This was direct, visual, unambiguous proof that RNA polymerases move along rDNA synthesizing progressively longer transcripts, exactly as the transcription model predicted, and it let researchers count the density of polymerases per gene and estimate elongation rates directly from images rather than inferring them indirectly.
Fluorescence recovery after photobleaching (FRAP) reveals liquid, not solid, structure (2000s). A pivotal shift in understanding the nucleolus came from live-cell imaging studies (notably from groups including Tom Misteli's and later Timothy Mitchison's, among others building on this foundation) that fused nucleolar proteins such as fibrillarin or nucleophosmin to GFP and photobleached a spot within the nucleolus. Fluorescence recovered within seconds to a couple of minutes, showing that nucleolar proteins are highly mobile and constantly exchanging with the surrounding nucleoplasm rather than being locked into a rigid scaffold. Complementary experiments showed that two nucleoli can fuse into one spherical droplet when they touch, and that nucleoli round up after being deformed — hallmark behaviors of liquids governed by surface tension, not solids. Together with the observation that low-dose actinomycin D (which selectively blocks RNA polymerase I) causes nucleoli to dissolve within tens of minutes, this evidence base established the now-standard model: the nucleolus is a phase-separated liquid condensate assembled around an actively transcribed RNA scaffold, not a pre-built compartment that gets filled.
Worked examples
Example 1 — Estimating rRNA gene dosage from a nucleolar organizer deletion. A diploid organism has two nucleolar organizer regions, one per homologous chromosome, each carrying 250 tandem copies of the rRNA gene. A geneticist recovers a partial deletion allele, bobbed-1 (bb⁻), that removes 70% of the rDNA repeats on one homolog only. Wild-type diploid rDNA dosage: 250 + 250 = 500 copies. Heterozygote (one wild-type NOR, one bb⁻ NOR): 250 + (250 × 0.30) = 250 + 75 = 325 copies, or 65% of wild-type dosage. If a second independent deletion allele removing 40% of repeats is combined in trans (bb⁻/bb⁻ compound heterozygote, each homolog independently deleted): (250 × 0.30) + (250 × 0.60) = 75 + 150 = 225 copies, or 45% of wild-type dosage. Ritossa and Spiegelman's hybridization method predicts, and experimentally confirmed, that the amount of rRNA-hybridizing DNA detected scales linearly with these copy numbers. Phenotypically in Drosophila, reduced rDNA dosage below roughly 50% of wild-type produces the visible bobbed phenotype (short, thin bristles) because ribosome output becomes limiting in rapidly growing tissues such as bristle-forming cells — a direct, quantitative link between gene copy number, ribosome supply, and an organismal phenotype.
Example 2 — Estimating nucleolar transcriptional output in a growing cell. Consider a cultured human cell with 300 active rRNA gene copies (a mix of active NORs across its five acrocentric chromosome pairs; not all copies are transcribed at once — typically about half are silenced by heterochromatin). Suppose each active gene carries an average of 80 RNA polymerase I molecules simultaneously transcribing it (consistent with the dense polymerase loading seen in Miller spreads), and each polymerase elongates at roughly 40 nucleotides per second. Transcripts completed per gene per hour: the 47S pre-rRNA precursor is about 13,000 nucleotides long, so one full transcript takes 13,000 ÷ 40 = 325 seconds ≈ 5.4 minutes. With 80 polymerases per gene queued along its length, once the pipeline is full a new completed transcript emerges roughly every (325 s ÷ 80) ≈ 4 seconds per gene, i.e., about 15 transcripts per gene per minute. Across 150 active genes (half of 300): 150 × 15 = 2,250 pre-rRNA molecules completed per minute, or 135,000 per hour, from this one cell's active NORs. Since each pre-rRNA precursor eventually yields one 18S, one 5.8S, and one 28S rRNA (destined for one 40S and one 60S subunit, pending assembly with proteins and 5S rRNA), this single cell is capable of initiating well over 100,000 new ribosomal subunit precursors per hour — consistent with independent estimates that actively growing mammalian cells assemble on the order of several thousand ribosomes per minute. This calculation illustrates why even modest reductions in active NOR number or Pol I loading (as in ribosomopathies, discussed below) can create a substantial ribosome supply bottleneck.
Common misconceptions & traps
| Misconception | Why it's wrong |
|---|---|
| "The nucleolus is a static organelle enclosed by its own membrane." | It has no membrane; it is a liquid-like condensate built by phase separation around active rDNA transcription, and it dissolves when transcription stops. |
| "Ribosomes are fully assembled and functional while still inside the nucleolus." | Subunits leaving the nucleolus and the nucleus are still immature; final maturation and proofreading steps occur in the cytoplasm, and the small and large subunits only join into a working 80S ribosome during translation initiation. |
| "All rRNA is made in the nucleolus." | Three of the four rRNAs (18S, 5.8S, 28S) are transcribed there by RNA polymerase I, but 5S rRNA is transcribed separately by RNA polymerase III, largely in the nucleoplasm, and then imported. |
| "Every rRNA gene copy in the genome is actively transcribed at all times." | A substantial fraction of the ~200–400 rDNA repeats per cell are kept transcriptionally silent by heterochromatin marks; only a subset is active at any time, and this fraction is itself regulated by growth signals. |
| "Nucleolar size just reflects cell size, with no functional meaning." | Nucleolar size and number scale with ribosome biogenesis rate specifically, which is why enlarged, prominent nucleoli are a hallmark used in cancer pathology to flag hyperactive growth signaling, independent of overall cell size. |
The scientist behind it
Barbara McClintock's identification of the nucleolar organizer emerged from her painstaking cytogenetic work on maize chromosomes at Cornell and later Cold Spring Harbor Laboratory. Working before DNA was known to be the genetic material, she and her contemporaries relied entirely on light microscopy of stained, squashed chromosomes to correlate visible chromosomal landmarks with heritable traits and cellular structures. Her 1934 paper describing the nucleolar organizer showed extraordinary rigor: by studying chromosome fragments produced by X-ray-induced breaks, she demonstrated that nucleolus formation tracked with a specific physical chromosomal segment, establishing a causal (not merely correlative) link years before the molecular nature of that segment — tandemly repeated rRNA genes — was understood. This same meticulous, hypothesis-driven cytogenetic approach later led her to discover transposable elements, for which she received the Nobel Prize in Physiology or Medicine in 1983, decades after the initial work.
Origins · 1 minBarbara McClintock and how this was discovered
Where this matters today
Cancer diagnosis and biology. Pathologists have used enlarged, irregular nucleoli as a microscopic marker of malignancy since the 19th century, long before the mechanism was known; today this is understood mechanistically, since oncogenic signaling (e.g., MYC overexpression) drives ribosome biogenesis to fuel unchecked growth, making nucleolar hypertrophy a direct, visible readout of oncogenic drive. Drugs such as CX-5461 selectively inhibit RNA polymerase I transcription and are in clinical trials as a strategy to starve cancer cells of ribosome supply while sparing normal cells relatively better, because tumor cells are often more dependent on high Pol I output.
Ribosomopathies. A class of human genetic diseases, including Diamond-Blackfan anemia, Treacher Collins syndrome, and Shwachman-Diamond syndrome, arise from mutations in ribosomal proteins or assembly factors that impair nucleolar ribosome production. Curiously, these diseases produce tissue-specific defects (especially in blood and craniofacial development) despite ribosomes being needed in every cell, illustrating that some tissues have unusually low tolerance for reduced ribosome supply during rapid developmental proliferation.
Antibiotic and antifungal development. Because rRNA processing and nucleolar assembly pathways differ enough between species, understanding nucleolar assembly factors in pathogenic fungi and parasites has opened avenues for selective drugs that disrupt ribosome biogenesis in the pathogen while sparing the host's nucleolar machinery.
Basic cell biology and synthetic biology. The nucleolus remains the paradigm system for studying membraneless organelles and liquid-liquid phase separation, informing broader research into stress granules, P-bodies, and other biomolecular condensates now implicated in neurodegenerative diseases such as ALS and frontotemporal dementia, where aberrant phase transitions of RNA-binding proteins are a central disease mechanism.
Agricultural and reproductive biology. Amplification of rDNA and massive nucleolar activity in oocytes (used originally by Miller to visualize transcription so clearly) is exploited in reproductive biology and assisted reproduction research, since oocyte ribosome stockpiles determine early embryo developmental competence before the embryo's own genome activates.
Ask the tutor: Why does inhibiting nucleolar rRNA transcription trigger a p53-dependent stress response, and how do cancer cells exploit or evade this checkpoint?
Why doesn't the nucleolus have a membrane like other organelles?
The nucleolus doesn't need a membrane because it is built by liquid-liquid phase separation rather than by enclosing a compartment with a lipid bilayer. Proteins like nucleophosmin and fibrillarin contain intrinsically disordered regions that make many weak, transient contacts with each other and with rRNA. This drives spontaneous demixing from the surrounding nucleoplasm into a distinct liquid droplet, much as oil separates from water, concentrated locally around actively transcribed ribosomal RNA genes. Because the whole structure depends on continuous transcription supplying fresh RNA scaffold, blocking RNA polymerase I causes the nucleolus to dissolve within roughly half an hour, something a true membrane-bound organelle would not do.
How many nucleoli does a human cell have, and why does the number vary?
Humans have five pairs of acrocentric chromosomes (13, 14, 15, 21, 22), each carrying a nucleolar organizer region, so a diploid cell has up to ten potential NOR sites. Early in interphase, active NORs each nucleate a small nucleolus, but as the cell cycle proceeds these frequently fuse into one, two, or a few larger nucleoli through liquid droplet fusion. The final number and size seen under a microscope therefore depends on how many NORs are transcriptionally active and how much fusion has occurred, which is why nucleolar number and size vary between cell types and growth states, and why enlarged nucleoli signal high ribosome biogenesis activity.
What is the difference between the fibrillar center, dense fibrillar component, and granular component?
These are the three nested subregions of the nucleolus, corresponding to sequential stages of ribosome production. The fibrillar center contains the rDNA itself along with RNA polymerase I machinery, poised to transcribe. The dense fibrillar component surrounds it and is where nascent pre-rRNA undergoes its earliest chemical modifications (via snoRNPs) and first cleavage events. The granular component is the outermost and usually largest region, where pre-ribosomal particles undergo the bulk of protein loading, compaction, and maturation before export. Maturing pre-rRNA and its associated particles physically move outward through these three zones as processing advances, so the nucleolus's internal structure directly maps onto the timeline of ribosome assembly.
Why do ribosomopathies cause tissue-specific diseases if ribosomes are needed everywhere?
Ribosomopathies are caused by mutations that impair ribosome biogenesis, yet their symptoms often concentrate in specific tissues, such as bone marrow in Diamond-Blackfan anemia or craniofacial structures in Treacher Collins syndrome. The leading explanation is that different tissues have very different demands for new ribosome synthesis during development, and rapidly proliferating progenitor cell populations (like erythroid precursors or neural crest cells) are far more sensitive to even modest ribosome shortfalls than slower-dividing tissues. Reduced ribosome supply in these vulnerable populations also triggers nucleolar stress signaling, releasing free ribosomal proteins that stabilize p53 and can push sensitive progenitor cells into apoptosis or growth arrest, compounding the tissue-specific damage.
How does the nucleolus connect to cancer, and why are Pol I inhibitors being tested as cancer drugs?
Oncogenic signals such as MYC amplification strongly upregulate RNA polymerase I transcription to fuel the massive ribosome production that rapid tumor cell growth requires, which is why enlarged nucleoli are a long-standing microscopic hallmark of malignancy. Because many cancer cells become unusually dependent on sustained high ribosome output, selectively inhibiting RNA polymerase I (for example with the drug CX-5461) can trigger nucleolar stress and p53-dependent cell death preferentially in tumor cells, while normal cells with lower ribosome demand tolerate the same inhibition better. This strategy is being tested clinically as a way to exploit cancer's dependence on nucleolar hyperactivity as a selective vulnerability.
Is the 5S rRNA actually made in the nucleolus?
No — this is a common point of confusion. Three of the four rRNAs used in the ribosome (18S, 5.8S, 28S) are transcribed together as one long precursor by RNA polymerase I directly inside the nucleolus. The fourth, 5S rRNA, is transcribed separately by RNA polymerase III, mostly in the nucleoplasm outside the nucleolus proper. The 5S rRNA is then assembled with the ribosomal proteins RPL5 and RPL11 into a small ribonucleoprotein complex that is imported into the nucleolus and incorporated into the maturing large (60S) ribosomal subunit, joining the RNA polymerase I-derived rRNAs mid-assembly.
What happens if a pre-ribosomal particle fails quality control?
Assembly of ribosomal subunits proceeds through an ordered series of checkpoints, where each cleavage or protein-loading step is a prerequisite for the next. If an early step fails — for instance, if a required assembly factor cannot bind, or a cleavage site is not properly modified — later steps cannot occur, and the defective intermediate stalls rather than proceeding to a functional ribosome. Stalled or misassembled intermediates are recognized and targeted for degradation by nuclear surveillance machinery (including exosome-mediated RNA decay pathways), preventing faulty, potentially error-prone ribosomes from ever reaching the cytoplasm and being used for translation.